Case Reports in Pathology / 2021 / Article / Tab 1

Case Report

Cutaneous Coinfection of Cytomegalovirus and Mycobacterium chelonae Accelerated by Immunosuppression

Table 1

Antibodies used in the present study.

Target antigenAnimal/cloneDilutionAntigen retrievalSource

Bacillus Calmette-Guérin (BCG)Rabbit antiserum1 : 10,000NoneAgilent
MPT64 (RV1980C, 24 kDa protein)Rabbit antiserum1 : 800HIER in 10 mM CB (pH 6)Abcam
LAM (lipoarabinomannan)Mouse TMDU31 : 1,000HIER in 10 mM CB (pH 6)MBL
PAB (Propionibacterium acnes-specific lipoteichoic acid)Mouse TMDU21 : 4,000HIER in 10 mM CB (pH 6)MBL
Bacillus cereusRabbit antiserum1 : 500HIER in 10 mM CB (pH 6)Abcam
Treponema pallidumRabbit antiserum1 : 1,000HIER in 1 mM EDTA (pH 8)BM
Escherichia coliRabbit antiserum1 : 20,000Proteinase K digestionAgilent

MPT: mycobacterial protein tuberculosis; HIER: heat-induced epitope retrieval; CB: citrate buffer; EDTA: ethylenediamine tetraacetic acid; Agilent: Agilent Technologies (Santa Clara, CA, USA); MBL: Medical and Biological Laboratories (Nagoya, Japan); Abcam: Abcam plc (Cambridge, UK); BM: Biocare Medical LLC (Pacheco, Philippines).